openPR Logo
Press release

Genital Herpes Research and Development Pipeline Market 2022 Key Country Analysis - AiCuris GmbH & Co. KG, AlphaVax, Inc., Foamix Pharmaceuticals Ltd., Genocea Biosciences, Inc., GenVec, Inc., Vaccibody AS

04-21-2022 11:01 AM CET | Advertising, Media Consulting, Marketing Research

Press release from: ReportsnReports

Genital Herpes Research and Development Pipeline Market report makes to thrive in the competitive market by giving knowhow of consumer's demands, preferences, attitudes and their changing tastes about the specific product. This market report estimates the growth rate and the market value based on market dynamics and growth inducing factors. Additionally, businesses can get highly benefited with this information to decide on their production and marketing strategies. All the major topics of the market research analysis are covered here that includes market definition, market segmentation, competitive analysis, major developments in the market, and top-notch research methodology.

Get FREE Sample Copy of this Report with Graphs and Charts at: https://www.reportsnreports.com/contacts/requestsample.aspx?name=5623455

Genital Herpes Research and Development Pipeline Market By Company

- AiCuris GmbH & Co. KG
- AlphaVax, Inc.
- Foamix Pharmaceuticals Ltd.
- Genocea Biosciences, Inc.
- GenVec, Inc.
- Immune Design Corp.
- Immunovaccine, Inc.
- Mymetics Corporation
- NanoBio Corporation
- NanoViricides, Inc.
- PaxVax
- Profectus BioSciences, Inc.
- Sanofi Pasteur SA
- Spider Biotech
- Starpharma Holdings Limited
- Vaccibody AS
- Vaxart, Inc.
- Vical Incorporated.

This report focuses on the global Genital Herpes Research and Development Pipeline status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Genital Herpes Research and Development Pipeline development in North America, Europe, Asia-Pacific, Latin America and Middle East & Africa, etc.

Genital Herpes Research and Development Pipeline Market Segment by Type

- Acyclovir
- Aspidasept
- G-103
- GEN-003
- GV-2207
- HerpeCide-I
- HSV-529
- Pritelivir
- SB-105A10

Genital Herpes Research and Development Pipeline Market Segment by Application

- Hospital
- Clinic

Genital Herpes Research and Development Pipeline Market By Region

- North America
- Europe
- Asia-Pacific
- Latin America
- Middle East & Africa

Direct Purchase of Genital Herpes Research and Development Pipeline Market Research Report at: https://www.reportsnreports.com/purchase.aspx?name=5623455

Table of Contents

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Genital Herpes Research and Development Pipeline Market Size Growth Rate by Type (2022-2028)
1.2.2 Acyclovir
1.2.3 Aspidasept
1.2.4 G-103
1.2.5 GEN-003
1.2.6 GV-2207
1.2.7 HerpeCide-I
1.2.8 HSV-529
1.2.9 Pritelivir
1.2.10 SB-105A10
1.3 Market by Application
1.3.1 Global Genital Herpes Research and Development Pipeline Market Share by Application (2022-2028)
1.3.2 Hospital
1.3.3 Clinic
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Genital Herpes Research and Development Pipeline Market Size
2.2 Genital Herpes Research and Development Pipeline Market Size by Regions
2.2.1 Genital Herpes Research and Development Pipeline Growth Rate by Regions (2022-2028)
2.2.2 Genital Herpes Research and Development Pipeline Market Share by Regions (2022-2028)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Use Cases
3 Key Players
3.1 Genital Herpes Research and Development Pipeline Revenue by Players (2022 & 2028)
3.2 Genital Herpes Research and Development Pipeline Key Players Headquarters and Area Served
3.3 Key Players Genital Herpes Research and Development Pipeline Product/Solution/Service
3.4 Date of Enter into Genital Herpes Research and Development Pipeline Market
3.5 Mergers & Acquisitions, Expansion Plans
4 Breakdown by Type and by Application
4.1 Global Genital Herpes Research and Development Pipeline Market Size by Type (2022-2028)
4.2 Global Genital Herpes Research and Development Pipeline Market Size by Application (2022-2028)
5 North America
5.1 North America Genital Herpes Research and Development Pipeline Market Forecast (2022-2028)
5.2 Genital Herpes Research and Development Pipeline Key Players in North America
5.3 North America Genital Herpes Research and Development Pipeline Market Size by Type
5.4 North America Genital Herpes Research and Development Pipeline Market Size by Application
6 Europe
6.1 Europe Genital Herpes Research and Development Pipeline Market Forecast (2022-2028)
6.2 Genital Herpes Research and Development Pipeline Key Players in Europe
6.3 Europe Genital Herpes Research and Development Pipeline Market Size by Type
6.4 Europe Genital Herpes Research and Development Pipeline Market Size by Application
7 Asia-Pacific
7.1 Asia-Pacific Genital Herpes Research and Development Pipeline Market Forecast (2022-2028)
7.2 Genital Herpes Research and Development Pipeline Key Players in Asia-Pacific
7.3 Asia-Pacific Genital Herpes Research and Development Pipeline Market Size by Type
7.4 Asia-Pacific Genital Herpes Research and Development Pipeline Market Size by Application
8 Rest of World
8.1 Latin America
8.1.1 Latin America Genital Herpes Research and Development Pipeline Market Analysis
8.1.2 Key Players in Latin America
8.2 Middle East & Africa
8.2.1 Middle East & Africa Genital Herpes Research and Development Pipeline Market Analysis
8.2.2 Key Players in Middle East & Africa
9 International Player Profiles

Inquire for Discount: https://www.reportsnreports.com/contacts/discount.aspx?name=5623455

About Us
ReportsnReports.com is your single source for all market research needs. Our database includes 500,000+ market research reports from over 95 leading global publishers & in-depth market research studies of over 5000 micro markets. With comprehensive information about the publishers and the industries for which they publish market research reports, we help you in your purchase decision by mapping your information needs with our huge collection of reports.

Contact Us
Corporate Headquarters
Tower B5, office 101,
Magarpatta SEZ,
Hadapsar, Pune-411013, India
+ 1 888 391 5441
sales@reportsandreports.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Genital Herpes Research and Development Pipeline Market 2022 Key Country Analysis - AiCuris GmbH & Co. KG, AlphaVax, Inc., Foamix Pharmaceuticals Ltd., Genocea Biosciences, Inc., GenVec, Inc., Vaccibody AS here

News-ID: 2608077 • Views:

More Releases from ReportsnReports

DeviceCon Series 2024 - UK Edition | MarketsandMarkets
DeviceCon Series 2024 - UK Edition | MarketsandMarkets
Future Forward: Redefining Healthcare with Cutting-Edge Devices Welcome to DeviceCon Series 2024 - Where Innovation Meets Impact! Join us on March 21-22 at Millennium Gloucester Hotel, 4-18 Harrington Gardens, London SW7 4LH for a groundbreaking convergence of knowledge, ideas, and technology. MarketsandMarkets proudly presents the DeviceCon Series, an extraordinary blend of four conferences that promise to redefine the landscape of innovation in medical and diagnostic devices. Register Now @ https://events.marketsandmarkets.com/devicecon-series-uk-edition-2024/register MarketsandMarkets presents
5th Annual MarketsandMarkets Infectious Disease and Molecular Diagnostics Conference Promises New Trends and Insights in Diagnosis
5th Annual MarketsandMarkets Infectious Disease and Molecular Diagnostics Confer …
London, March 7, 2024 - MarketsandMarkets is thrilled to announce the eagerly awaited 5th Annual Infectious Disease and Molecular Diagnostics Conference, scheduled to take place on March 21st - 22nd, 2024, at the prestigious Millennium Gloucester Hotel, located at 4-18 Harrington Gardens, London SW7 4LH. This conference promises to be a groundbreaking event, showcasing the latest trends and insights in diagnosis, as well as unveiling cutting-edge technologies that are revolutionizing the
Infection Control, Sterilization & Decontamination Conference |21st - 22nd March 2024| Challenges and Factors affecting in Sterilization of medical devices and more
Infection Control, Sterilization & Decontamination Conference |21st - 22nd March …
MarketsandMarkets is pleased to announce its 8th Annual Infection Control, Sterilisation, and Decontamination in Healthcare Conference, which will take place March 21-22, 2024, in London, UK. With the increased risk of infection due to improper sterilisation and decontamination practices, the safety of patients and healthcare workers is of paramount importance nowadays. Enquire Now @ https://events.marketsandmarkets.com/infection-control-sterilization-and-decontamination-conference/ This conference aims to bring together all the stakeholders to discuss the obstacles in achieving
Breast Augmentation Market Key Players, Demands, Cost, Size, Procedure, Shape, Surface and Forecast to 2025
Breast Augmentation Market Key Players, Demands, Cost, Size, Procedure, Shape, S …
The global Breast Augmentation Market in terms of revenue was estimated to be worth $900 million in 2020 and is poised to reach $1,692 million by 2025, growing at a CAGR of 13.4% from 2020 to 2025. The new research study consists of an industry trend analysis of the market. The new research study consists of industry trends, pricing analysis, patent analysis, conference and webinar materials, key stakeholders, and buying

All 5 Releases


More Releases for Genital

Genital Warts Pipeline Insights Report 2025 | DelveInsight
DelveInsight's, "Genital Warts Pipeline Insight 2025" report provides comprehensive insights about 30+ companies and 30+ pipeline drugs in Genital Warts pipeline landscape. It covers the Genital Warts pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space. Explore the comprehensive insights by DelveInsight and stay ahead
Rising Sexual Health Awareness To Drive Genital Herpes Market Growth: A Key Driv …
The Genital Herpes Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories]. What Is the Current Genital Herpes Market Size and Its Estimated Growth Rate? The genital herpes market has experienced strong growth in recent years. It will grow from $2.19 billion in 2024 to $2.34 billion
Rising Sexually Transmitted Infection (STI) Rates Propel Growth In Genital Warts …
The Genital Warts Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories]. What Is the Genital Warts Market Size and Projected Growth Rate? The genital warts market has grown strongly in recent years. It is set to increase from $1.97 billion in 2024 to $2.08 billion in
Genital Warts Market - Revolutionizing Intimate Care: Transforming the Genital W …
Newark, New Castle, USA: The "Genital Warts Market" provides a value chain analysis of revenue for the anticipated period from 2023 to 2031. The report will include a full and comprehensive analysis of the business operations of all market leaders in this industry, as well as their in-depth market research, historical market development, and information about their market competitors. Genital Warts Market: https://www.growthplusreports.com/report/genital-warts-market/8677 This latest report researches the industry structure, sales, revenue,
Genital Herpes - Pipeline Review, H1 2017
ReportsWorldwide has announced the addition of a new report title Genital Herpes - Pipeline Review, H1 2017 to its growing collection of premium market research reports. Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Genital Herpes - Pipeline Review, H1 2017, provides an overview of the Genital Herpes (Infectious Disease) pipeline landscape. Genital herpes is a common sexually transmitted infection that affects both men and women. Genital herpes is caused
Genital Herpes - Pipeline Review, H1 2017
ReportsWorldwide has announced the addition of a new report title Thyroid Cancer - Pipeline Review, H1 2017 to its growing collection of premium market research reports. Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Thyroid Cancer – Pipeline Review, H1 2017, provides an overview of the Thyroid Cancer (Oncology) pipeline landscape. Thyroid cancer is a cancer that starts in the thyroid gland. Symptoms include lump that can be felt through